U.K. to Tighten Pharma Rules as Glaxo Avoids Prosecution
Jacob Goldstein
GlaxoSmithKline won’t be prosecuted for its handling of safety data on the antidepressant Seroxat (sold in the U.S. as Paxil), U.K. regulators have decided. But the government isn’t pleased with the way the company acted in the case, and it plans to push for changes in the law as a result.
A four-year […]